Skip to content

What Is The Cost Of Vertex Pharmaceuticals’ Orphan Drug Kalydeco (Ivacaftor) In England ?

December 20, 2012

       Per an article titled, “Cystic Fibrosis Drug Kalydeco gets NHS funding go-ahead”, in The Times UK :

  1. ” The cost of making it (Kalydeco) available to the 270 patients in England who are eligible will account for about ½ of the NHS budget for Cystic Fibrosis” 
  2. Cost of Kalydeco is about 200,000 British Pound Sterling/year/patient or about $325,000 US Dollars/year/patient.

        Per a December 19, 2012 BioCentury.com article titled, “NHS to reimburse for Kalydeco in England”, the Kalydeco’s “annual list price in the UK is L182,625 ($294,651 US), with about 270 eligible patients in England”.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: